BIOLASE Showcases Breakthrough YSGG Laser Protocol for Predictable Periodontitis Treatment at AAP 2025

Rhea-AI Summary

BIOLASE (NASDAQ:BIOLQ) will present a new Er,Cr:YSGG YSGG laser resective protocol for treating periodontitis at the American Academy of Periodontology (AAP) 2025 Corporate Forum in Toronto, Oct 15–18.

The featured session by Philip Kang, DDS on Oct 15 at 2:05 PM describes a standardized, minimally invasive approach aiming for predictable pocket elimination, effective bacterial decontamination, and precise osseous contouring. BIOLASE will demonstrate the Waterlase iPlus Premier Edition at Booth #1004 with hands-on demos and giveaways. The release cites a blind McGuire Institute study in the Journal of Periodontology reporting less bleeding/swelling, faster procedures, and superior patient-reported outcomes versus open flap techniques.

News Market Reaction – BIOLQ

%

1 alert

% News Effect

On the day this news was published, BIOLQ declined NaN%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

TORONTO, Oct. 14, 2025 /PRNewswire/ -- BIOLASE, the global leader in dental laser technology, will present a major advancement in periodontal care during the American Academy of Periodontology (AAP) 2025 Corporate Forum in Toronto, October 15–18.

Philip Kang, DDS, will lead a featured session titled "Redefining Periodontitis Treatment: A Novel YSGG Laser-Resective Protocol for Predictable Pocket Elimination" on Wednesday, October 15 at 2:05 PM (Room 709, MTCC).

The presentation introduces an innovative Er,Cr:YSGG laser-assisted surgical protocol designed to standardize resective periodontitis treatment, achieving greater predictability, efficiency, and patient comfort. Attendees will gain insights into how the new technique enables:

• Predictable pocket elimination
  
  
• Effective bacterial decontamination
  
  
• Precise osseous contouring with minimal invasiveness

This novel protocol leverages YSGG laser technology to deliver consistent, long-term periodontal health—and positions the laser as an essential tool in modern periodontics.

Hands-On Demos and Giveaways at BIOLASE Booth #1004

BIOLASE invites attendees to visit Booth #1004 for live demonstrations of the Waterlase iPlus Premier Edition^™, the company's most advanced all-tissue laser. Visitors who test drive the Waterlase iPlus will receive a complimentary BIOLASE travel mug.

The Waterlase iPlus is supported by a landmark blind study designed by The McGuire Institute^™ and published in the Journal of Periodontology, confirming:

• Less bleeding, swelling, and postoperative discomfort
  
  
• Faster procedures with equivalent results to open flap techniques
  
  
• Superior patient-reported outcomes consistent with AAP Best Evidence Consensus recommendations

"BIOLASE is committed to advancing the science and precision of laser dentistry to support better patient care worldwide," said Dr. Kwang Bum Park, CEO of BIOLASE. "Our presence at AAP 2025 demonstrates our continued dedication to innovation that empowers clinicians and transforms treatment outcomes."

BIOLASE^®, Waterlase^® and Waterlase iPlus^® are registered trademarks of BIOLASE MG LLC.

For updates and information on BIOLASE and laser dentistry, find BIOLASE online at www.biolase.com, Facebook at www.facebook.com/biolase, Instagram at www.instagram.com/biolase_official, and LinkedIn at www.linkedin.com/company/biolase/.

About BIOLASE
BIOLASE is the world's leading innovator in dental laser technology, manufacturing high-performance laser systems that advance dentistry and improve patient experiences. With a legacy of over three decades, BIOLASE continues to define the future of minimally invasive dentistry.

Media Contact
Denise Arterberry
Marketing Manager, BIOLASE
darterberry@biolase.com
949.226.8190

FAQ

When will BIOLASE (BIOLQ) present the YSGG laser protocol at AAP 2025?

The presentation is scheduled for Oct 15, 2025 at 2:05 PM in Room 709 at the MTCC.

What will BIOLASE demonstrate at Booth #1004 during AAP 2025?

BIOLASE will offer live demos of the Waterlase iPlus Premier Edition, hands-on sessions, and a complimentary travel mug for test drives.

What are the claimed benefits of the new YSGG protocol announced by BIOLASE (BIOLQ)?

The protocol aims for predictable pocket elimination, effective bacterial decontamination, and precise osseous contouring with minimal invasiveness.

Does BIOLASE cite clinical evidence for the Waterlase iPlus results?

Yes; the release references a blind study by The McGuire Institute published in the Journal of Periodontology reporting less bleeding and faster procedures versus open flap techniques.

How can investors or clinicians get more information from BIOLASE after AAP 2025?

BIOLASE directs audiences to its website and social channels (website, Facebook, Instagram, LinkedIn) for updates and additional information.

Will BIOLASE provide hands-on training or materials at AAP 2025 to learn the new protocol?

Yes; BIOLASE invites attendees to live demonstrations and hands-on demos at Booth #1004 during the conference.